Brightfield Group logo

CBD: FDA Impact & the Path Forward

2022 Mid-Year US CBD Report

As the CBD industry moves forward without much-needed federal guidance, this year we've forecasted for two scenarios - with and without FDA regulation. This report will help you prepare for either eventuality while adding insights into top performers and key distribution channels.

Download Brightfield Group's US CBD 2022 mid-year market sizing report today.

You'll learn:

  • What's the projected revenue of the CBD market through 2027?
  • What is the forecasted impact of federal regulation?
  • Which brands are on top?
  • Which industry leaders are growing the fastest?
  • Which brands perform best in brick-and-mortar stores vs. online?
  • How the grocery channel is responding to risk, and which product types are pulling ahead as a result?
  • And much more
Q222_US-CBD_Market-Refresh_June-2022_Landing-Page-Graphic_FINAL
Platform
Blog
Company
Resources
Schedule a demo
Brightfield Group Logo